Psychemedics Short Long Term Debt Total from 2010 to 2024
PMD Stock | USD 2.55 0.09 3.41% |
Short and Long Term Debt Total | First Reported 1990-12-31 | Previous Quarter 2.6 M | Current Value 2.3 M | Quarterly Volatility 2.8 M |
Check Psychemedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Psychemedics main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.8 M, Interest Expense of 51.9 K or Total Revenue of 20.8 M, as well as many exotic indicators such as Price To Sales Ratio of 0.73, Dividend Yield of 0.0346 or PTB Ratio of 2.42. Psychemedics financial statements analysis is a perfect complement when working with Psychemedics Valuation or Volatility modules.
Psychemedics | Short Long Term Debt Total |
Latest Psychemedics' Short Long Term Debt Total Growth Pattern
Below is the plot of the Short Long Term Debt Total of Psychemedics over the last few years. It is Psychemedics' Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Psychemedics' overall financial position and show how it may be relating to other accounts over time.
Short Long Term Debt Total | 10 Years Trend |
|
Short Long Term Debt Total |
Timeline |
Psychemedics Short Long Term Debt Total Regression Statistics
Arithmetic Mean | 4,595,020 | |
Geometric Mean | 3,853,524 | |
Coefficient Of Variation | 48.62 | |
Mean Deviation | 1,882,659 | |
Median | 5,127,000 | |
Standard Deviation | 2,234,253 | |
Sample Variance | 5T | |
Range | 8.4M | |
R-Value | (0.11) | |
Mean Square Error | 5.3T | |
R-Squared | 0.01 | |
Significance | 0.69 | |
Slope | (56,020) | |
Total Sum of Squares | 69.9T |
Psychemedics Short Long Term Debt Total History
About Psychemedics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Psychemedics income statement, its balance sheet, and the statement of cash flows. Psychemedics investors use historical funamental indicators, such as Psychemedics's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although Psychemedics investors may use each financial statement separately, they are all related. The changes in Psychemedics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Psychemedics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Psychemedics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Psychemedics. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Short and Long Term Debt Total | 2.3 M | 3.3 M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Psychemedics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of Psychemedics Correlation against competitors. For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Psychemedics Stock analysis
When running Psychemedics' price analysis, check to measure Psychemedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psychemedics is operating at the current time. Most of Psychemedics' value examination focuses on studying past and present price action to predict the probability of Psychemedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psychemedics' price. Additionally, you may evaluate how the addition of Psychemedics to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Psychemedics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psychemedics. If investors know Psychemedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psychemedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Dividend Share 0.07 | Earnings Share (0.72) | Revenue Per Share 3.85 | Quarterly Revenue Growth (0.12) |
The market value of Psychemedics is measured differently than its book value, which is the value of Psychemedics that is recorded on the company's balance sheet. Investors also form their own opinion of Psychemedics' value that differs from its market value or its book value, called intrinsic value, which is Psychemedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psychemedics' market value can be influenced by many factors that don't directly affect Psychemedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psychemedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Psychemedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psychemedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.